The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

Matthew R. Cooperberg*, Peter R. Carroll, Marc A. Dall'Era, Benjamin J. Davies, John W. Davis, Scott E. Eggener, Felix Y. Feng, Daniel W. Lin, Todd M. Morgan, Alicia K. Morgans, Daniel E. Spratt, Samir S. Taneja, David F. Penson

*Corresponding author for this work

Research output: Contribution to journalEditorial

4 Scopus citations

Abstract

We convened a multidisciplinary expert panel to make recommendations on current utility and future research needs for post-diagnosis prostate cancer biomarkers. The San Francisco Consensus Statement reflects on the rapid recent progress achieved, and the substantial work still ahead.

Original languageEnglish (US)
Pages (from-to)268-272
Number of pages5
JournalEuropean urology
Volume76
Issue number3
DOIs
StatePublished - Sep 2019

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement'. Together they form a unique fingerprint.

  • Cite this

    Cooperberg, M. R., Carroll, P. R., Dall'Era, M. A., Davies, B. J., Davis, J. W., Eggener, S. E., Feng, F. Y., Lin, D. W., Morgan, T. M., Morgans, A. K., Spratt, D. E., Taneja, S. S., & Penson, D. F. (2019). The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement. European urology, 76(3), 268-272. https://doi.org/10.1016/j.eururo.2019.05.013